In today’s Pharma Pulse, experts warn of zero-prefix collision risks in the NDC-12 transition, and the FDA grants accelerated ...
As the direct-to-patient (DTP) model gains traction across the pharmaceutical landscape, companies are grappling with one ...
In today's Pharma Pulse, the FDA flags misleading promotional claims from ImmunityBio regarding its cancer therapy and ...
Patient support programs continue to play a role in how pharmaceutical manufacturers address access and adherence challenges, ...
For more than a decade, drug shortages have been treated as a manufacturing problem. When shortages occur, the conversation ...
In the final installment of Pharmaceutical Commerce’s interview with Nareda Mills, global president of Patient Solutions at ...
Pharmaceutical companies are increasingly shifting their focus from healthcare providers to patients as the primary customer ...
Bioscience and artificial intelligence company Brightseed has launched the world’s first clinically validated enterprise ...
As global temperatures continue to rise and weather patterns grow more volatile, the pharmaceutical industry faces a mounting ...
Jordan Armstrong outlines how adaptable DTP programs can reduce barriers and accelerate patient access to therapy. As ...
Nordic Cold Chain Solutions (NCCS) has announced the launch of its GLP-1 & Small-Format Packaging Innovation Lab, a facility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results